Switching supplement manufacturers mid-growth is disruptive, and most brand owners wait too long to do it — absorbing late shipments, creeping reject rates, and stalled innovation because starting over feels worse. But staying with the wrong partner has a cost too, and it compounds quietly until a stockout or a failed batch forces your hand at the worst possible moment.
Here are six signs it’s time to switch your supplement manufacturer — and how to move without losing momentum.
An occasional out-of-spec batch happens. A trend doesn’t lie. Rising reject rates, customer complaints about taste, texture, or potency, and repeat deviations all point to a quality system that’s slipping. Your brand absorbs every one of those failures.
If your manufacturer can’t hold agreed timelines, you lose sales you already earned. Chronic late deliveries and missed POs mean their capacity or planning can’t keep up with you — and a brand that’s out of stock is teaching its customers to buy a competitor.
The partner who was perfect at 5,000 units can become the bottleneck at 50,000. If MOQs, lead times, and equipment can’t flex to your projections, you’ll outgrow them — and it’s far better to plan that move than to be forced into it.
A good manufacturer helps you improve the product — new formats, better bioavailability, line extensions. If every request is met with “we can’t do that here,” your roadmap is being capped by their capabilities, not your strategy.
CoAs that arrive late or not at all, vague answers on testing, resistance to a quality agreement — when basic documentation becomes a negotiation, you’re exposed every time the FDA or a retailer asks for proof. Transparency shouldn’t be this hard.
Slow responses, no named point of contact, problems you only discover after they’ve shipped — poor communication is usually the first symptom and the last straw. If you can’t get a straight answer before a launch, you won’t get one during a crisis.
The risk in switching is a botched handoff. A disciplined transition removes most of it:
| Step | What It Protects |
|---|---|
| Confirm you own the formula and data | Lets you move the formula at all |
| Run a tech transfer with pilot batches | Catches scaling issues before full production |
| Overlap production briefly | Prevents a stockout during the move |
| Sign a new quality agreement | Resets accountability from day one |
The single prerequisite is ownership. If you hold the formula and full specification, a clean tech transfer is straightforward. If the old manufacturer owns it, switching means redeveloping — which is exactly why ownership matters from the start.
Watch for trends, not incidents: rising rejects, repeated stockouts, an inability to scale, stalled innovation, documentation fights, and poor communication. Two or more sustained signs mean it’s time to plan a move.
The main risk is a poorly managed handoff. A structured tech transfer with pilot batches and a brief production overlap removes most of it and prevents a gap on the shelf.
Written ownership of the formula and access to the full specification and stability data. With those, a new qualified manufacturer can reproduce your product reliably.
Outgrowing your current manufacturer? UniWell Labs onboards brand owners with disciplined tech transfer, pilot validation, and the capacity to scale. Talk to our team about a smooth move.